legal

Pharmalot By Ed Silverman

Purdue says most creditors voted in favor of contentious bankruptcy plan

Pharmalot By Ed Silverman

States reach $26 billion deal with three wholesalers and J&J to end opioid lawsuits

Pharmalot By Ed Silverman

Three pharma wholesalers reach a $1.1 billion deal with New York over the opioid crisis

Pharmalot By Ed Silverman

As a key hearing nears, Justice Department calls Purdue’s bankruptcy plan unconstitutional

Hospitals By Harris Meyer — Kaiser Health News

Recent rulings may embolden hospital employees to speak publicly about safety issues

Pharmalot By Ed Silverman

Former Genentech scientist convicted of stealing trade secrets given to former JHL Biotech execs

Pharmalot By Ed Silverman

Purdue reaches deal with 15 states in a significant step toward bankruptcy plan approval

D.C. Diagnosis By Nicholas Florko

Are pharma mergers bad for biotech?

Pharmalot By Ed Silverman

Purdue wants to shower employees with nearly $35 million in different kinds of bonuses

Hospitals By Rachel Cohrs

Supreme Court to take up hospitals’ challenge to Medicare drug pay cuts

Politics By Rachel Cohrs

Washington’s antitrust push could limit Amazon, Google’s health care ambitions

Pharmalot By Ed Silverman

Johnson & Johnson agrees to pay $230 million to settle opioid case in New York

Pharmalot By Ed Silverman

Pharmalittle: Biogen isn’t the only company to make big bucks from its Alzheimer’s drug; EU extends Covid-19 vax export block

Pharmalot By Ed Silverman

Medical journal argues a drug maker’s libel suit is really a public relations campaign to chill research

Pharmalot By Ed Silverman

European Union loses bid for faster deliveries of AstraZeneca Covid-19 vaccine

Pharmalot By Ed Silverman

Centene to pay $143 million to two states to settle allegations of overcharging Medicaid

Pharmalot By Ed Silverman

Mississippi becomes the first state to jointly sue drug makers and PBMs over the cost of insulin

Pharmalot By Ed Silverman

After repeated losses in the U.S., Catalyst wins a victory in Canada over a rare disease drug

Pharmalot By Ed Silverman

Former Celgene shareholders claim Bristol Myers reaped a $6.4 billion windfall by delaying a drug approval

Pharmalot By Ed Silverman

What’s in a name? Spark Therapeutics sues Bluebird Bio over the use of the word ‘spark’

Pharmalot By Ed Silverman

Brazil’s Supreme Court rules that patent extension rules are unconstitutional

Pharmalot By Ed Silverman

Sanofi is accused of ‘widespread destruction’ of company e-mails tied to Zantac recall

Pharmalot By Ed Silverman

Incyte pays $12.6 million to resolve claims it paid drug kickbacks through charity

Pharmalot By Ed Silverman

Gilead sues Russia over a compulsory license issued to a company making remdesivir

Pharmalot By Ed Silverman

A drug maker sues a medical journal, its editor, and several authors for libel